Home/Filings/4/0001209191-17-031515
4//SEC Filing

GLYCOMIMETICS INC 4

Accession 0001209191-17-031515

$CBIOCIK 0001253689operating

Filed

May 10, 8:00 PM ET

Accepted

May 11, 4:00 PM ET

Size

7.8 KB

Accession

0001209191-17-031515

Insider Transaction Report

Form 4
Period: 2017-05-10
Magnani John L.
DirectorVP of Research, CSO
Transactions
  • Exercise/Conversion

    Common Stock

    2017-05-10$1.12/sh+8,928$9,99999,302 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2017-05-108,928213,967 total
    Exercise: $1.12Exp: 2021-01-04Common Stock (8,928 underlying)
Holdings
  • Common Stock

    (indirect: By GlycoTech Corporation)
    4,845
Footnotes (2)
  • [F1]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.
  • [F2]One-fourth of the shares underlying this option vested on January 4, 2012, with the remainder vesting in 36 equal monthly installments thereafter.

Issuer

GLYCOMIMETICS INC

CIK 0001253689

Entity typeoperating
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001253689

Filing Metadata

Form type
4
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:00 PM ET
Size
7.8 KB